Tilray Shares Volatile After Cannabis Company Announces M&A Deal, Q3 Revenue Miss

Shares of Tilray Inc TLRY are trading near flat in Monday's after-hours session after the company reported third-quarter financial results — and an acquisition. Here’s what investors need to know.

By The Numbers: Tilray reported third-quarter revenues of $145.6 million, which missed the average analyst estimate of $202.47 million, according to Benzinga Pro.

The company posted a loss of 4 cents per share.

Tilray had $164.99 million in cash and cash equivalents and marketable securities as of Feb. 28, 2023.

"During the quarter, we continued to focus on our highest priorities: sustaining and growing the top-line across core markets and geographies while optimizing the platform to achieve positive free cash flow on an accelerated timeline,” CEO Irwin Simon said in a statement. 

Heads-up: The Benzinga Cannabis Capital Conference is returning to the Fontainebleau Miami Beach Hotel April 11-12. 

The company also announced its acquisition plans for Canadian cannabis producer Hexo Corp. HEXO, which is expected to cost around $250 million, according to Benzinga Pro.

“We are incredibly excited about our combined prospects moving forward with HEXO and expect a seamless integration of HEXO’s business into our efficient, built-to-last platform,” Simon continued.

Tilray is set to acquire Hexo by utilizing the $173-million secured convertible note it obtained from Hexo's former creditor in July 2022, thereby obtaining almost 49% of the company's equity, and paying an additional $75 million to purchase the remaining outstanding shares.

The company said said existing shareholders of both Tilray and Hexo are expected to hold approximately 97% and 3% of Tilray, respectively, on a pro forma basis.

TLRY Price Action: Tilray has a 52-week high of $6.80 and a 52-week low of $2.28. The stock was trading near flat at $2.65 in the after-hours session.

Photo via Shutterstock.